Clinical Trial Update: A Clinical Study to Assess Safety, Efficacy and In-use Tolerability of Different Dosages of Hair Growth Products in Patients With Mild to Moderate Androgenic Alopecia (Grade I to III). [NA]

View source ↗

Summary

This clinical study aims to evaluate safety, efficacy, and in-use tolerability of different dosages of hair growth products in patients with mild to moderate an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Snippet

Sponsor: NovoBliss Research Pvt Ltd | Conditions: Androgenic Alopecia | NA | Status: NOT_YET_RECRUITING